# Points of Discussion - Alternative Therapies: Part Two Page: https://stenobird.com/podcast/pedra-pearls-1565679/points-of-discussion-alternative-therapies-part-two Text version: https://stenobird.com/podcast/pedra-pearls-1565679/points-of-discussion-alternative-therapies-part-two.md Podcast: [PeDRA Pearls](https://stenobird.com/podcast/pedra-pearls-1565679) Published: 2025-12-29T13:00:00+00:00 Episode link: https://pedra-podcasts.captivate.fm Audio file: https://episodes.captivate.fm/episode/f2083f8e-d342-4527-a9cd-00dc0c7e0055.mp3 Processing state: not_requested JSON: https://stenobird.com/v1/public/podcasts/pedra-pearls-1565679/episodes/points-of-discussion-alternative-therapies-part-two Duration seconds: 1494 ## Resource This is part two of our conversation on complementary and alternative medicine in pediatric dermatology. While these approaches may offer benefits, they can also carry risks—especially when misinformation spreads quickly online. In this episode, Dr. Peter Lio and Dr. Larry Eichenfield explore how pediatric dermatologists can assess safety, address popular but unproven therapies, and support families in making informed decisions, all while maintaining strong, trusting clinical relationships. Special thanks to Incyte for supporting this independent education program. Tell us about yourself by filling out t his 1-question survey . ## Actions - request_transcript: `POST https://stenobird.com/v1/public/podcasts/pedra-pearls-1565679/episodes/points-of-discussion-alternative-therapies-part-two/transcription-requests` — Idempotently request low-priority transcript generation for this episode. - read_markdown: `GET https://stenobird.com/podcast/pedra-pearls-1565679/points-of-discussion-alternative-therapies-part-two.md` — Read the agent-friendly Markdown representation of this episode resource. A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed. ## Transcript Full transcripts are not published on public pages unless there is a clear rights basis.